Heterotrimeric G protein signaling: Role in asthma and allergic inflammation

Journal of Allergy and Clinical Immunology

Volumn 109, Issue 4, 2002, Pages 592-602

  Johnson, Eric N ^a   Druey, Kirk M ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

Allergic rhinitis; Asthma; G proteins; Inflammation; Signal transduction

Indexed keywords

ADRENALIN; ALLERGEN; ANTIHISTAMINIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; FORSKOLIN; G PROTEIN COUPLED RECEPTOR; G PROTEIN RECEPTOR KINASE; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATASE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LIGAND; MONTELUKAST; PHOSPHODIESTERASE INHIBITOR; PHOSPHOTRANSFERASE; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; PROTEIN SUBUNIT; RGS PROTEIN; SALBUTAMOL; THEOPHYLLINE; UNCLASSIFIED DRUG; VASOACTIVE INTESTINAL POLYPEPTIDE;

ALLERGY; ASTHMA; ATOPY; CELL ACTIVATION; CELL PROLIFERATION; DRUG EFFECT; DRUG MECHANISM; HUMAN; IMMUNE SYSTEM; IMMUNOCOMPETENT CELL; INFLAMMATION; INFLAMMATORY CELL; MOLECULAR MECHANICS; NERVOUS SYSTEM; NONHUMAN; PATHOGENESIS; PATHOPHYSIOLOGY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STRUCTURE; REGULATORY MECHANISM; REVIEW; RHINITIS; SIGNAL TRANSDUCTION; SMOOTH MUSCLE TONE; STRUCTURE ACTIVITY RELATION; TH1 CELL; TH2 CELL;

EID: 0036223505     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2002.122636     Document Type: Article

References (93)

1. Mediator antagonists in the treatment of allergic disease
2. G protein-coupled receptors II. Mechanism of agonist activation
3. G proteins: Transducers of receptor-generated signals
4. Heterotrimeric G proteins: Organizers of transmembrane signals
5. The many faces of G protein signaling
6. Kinetic control of guanine nucleotide binding to soluble Gαq
7. G protein GTPase-activating proteins: Regulation of speed, amplitude, and signaling selectivity
8. Rapid GTP binding and hydrolysis by Gαq promoted by receptor and GTPase-activating proteins
9. Inositol lipids and cell proliferation
10. Regulation of second messengers associated with airway smooth muscle contraction and relaxation
11. Regulation and tuning of smooth muscle myosin
12. Protein kinase C isoenzymes: A review of their structure, regulation and role in regulating airway smooth muscle tone and mitogenesis
13. Increased expression of G12 and G13 proteins in bronchial smooth muscle of airway hyperresponsive rats
14. ++ sensitization of bronchial smooth muscle contraction in antigen-induced airway hyperresponsive rats
15. The role of Rho in G-protein coupled receptor signal transduction
16. Control of airway smooth muscle tone, II: Pharmacology of relaxation
17. Ca channels in airway smooth muscle by cAMP-dependent and independent mechanisms
18. +-channel activity in tracheal myocytes by phosphorylation
19. Mechanisms of airway smooth muscle response to isoproterenol and theophylline
20. cAMP-phosphodiesterase inhibitors and tracheal smooth muscle relaxation
21. Airway remodeling in the pathogenesis of asthma
22. Phosphatidylinositol 3-kinase mediates mitogen-induced human airway smooth muscle cell proliferation
23. The seven-transmembrane-spanning receptors for endothelin and thrombin cause proliferation of airway smooth muscle cells and activation of the extracellular regulated kinase and c-junNH2-terminal kinase groups of mitogen-activated protein kinases
24. Arterial and bronchoalveolar lavage fluid endothelin-1 concentrations in asthma
25. Mechanisms of proliferation synergy by receptor tyrosine kinase and G protein-coupled receptor activation in human airway smooth muscle
26. Beta2-adrenergic receptor agonists and cAMP arrest human cultured airway smooth muscle cells in the G(1) phase of the cell cycle: Role of proteasome degradation of cyclin D1
27. Induction of inducible nitric-oxide synthase by the heterotrimeric G protein Gα13
28. Inducible nitric oxide synthase inhibitors suppress airway inflammation of mice through downregulation of chemokine expression
29. β2-adrenoceptor agonists inhibit release of eosinophil activating cytokines from human airway smooth muscle cells
30. Effects of prostaglandin E2 and cAMP elevating drugs on GM-CSF release by cultured human airway smooth muscle cells. Relevance to asthma therapy
31. Sphingosine 1-phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthma
32. Regulation of TNF-alpha-induced eotaxin release from cultured human airway smooth muscle cells by beta2-agonists and corticosteroids
33. Muscarinic receptors and control of airway smooth muscle
34. Excitatory non-adrenergic-non-cholinergic neuropeptides: Key players in asthma
35. Role of tachykinins in bronchial hyper-responsiveness
36. Role of tachykinins as contractile agonists of human airways in asthma
37. Mediators and reflex bronchoconstriction
38. Neural mechanisms in asthma
39. Heterotrimeric G protein signaling: Roles in immune function and fine-tuning by RGS proteins
40. Lsc is required for marginal zone B cells, regulation of lymphocyte motility and immune responses
41. Mice lacking the orphan G protein-coupled receptor G2A develop a late-onset autoimmune syndrome
42. Interaction between G proteins and tyrosine kinases upon T cell receptor-CD3-mediated signaling
43. Gα16, a G protein α subunit expressed in hematopoietic cells
44. Gα16 expression is up- and down-regulated following T-cell activation: Disruption of this regulation impairs activation-induced cell responses
45. Inhibition of TCR/CD3-mediated signaling by a mutant of the hematopoietically expressed G16 GTP-binding protein
46. G protein βγ subunits act on the catalytic domain to stimulate Bruton's agammaglobulinemia tyrosine kinase
47. Direct stimulation of Bruton's tyrosine kinase by Gq protein alpha-subunit
48. Augmentation of antigen receptor-mediated responses by histamine H1 receptor signaling
49. Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors
50. Effects of β-agonists on inflammatory cells
51. Regulatory effect of histamine H1 receptor antagonist on the expression of messenger RNA encoding CC chemokines in the human nasal mucosa
52. Chemokines and chemokines receptors; their role in allergic airway disease
53. Eotaxin potentiates antigen-dependent basophil IL-4 production
54. ++ in human eosinophils: Activation of purinergic P2Y receptors
55. Mast cell adenosine receptor characteristics and signaling
56. Characterization of the human cysteinyl leukotriene CysLT1 receptor
57. A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis
58. A second leukotriene B4 receptor, BLT2: A new therapeutic target in inflammation and immunological disorders
59. Signalling through the leukotriene B4 receptor involves both αi and α16, but not αq or α11 G-protein subunits
60. Endogenous platelet-activating factor is critically involved in effector functions of eosinophils stimulated with IL-5 or IgG
61. Bridging with GAPs: Receptor communication through RGS proteins
62. A pertussis toxin-sensitive process controls thymocyte emigration
63. Dissection of thymocyte signaling pathways by in vivo expression of pertussis toxin ADP-ribosyltransferase
64. Chemokines as regulators of T cell differentiation
65. A coordinated change in chemokines responsiveness guides plasma cell movements
66. Critical involvement of the chemotactic axis CXCR4/SDFIα in the inflammatory component of allergic airway disease
67. Enhanced production of CC-chemokines (RANTES, MCP-1, MIP-lapha, MIP-1beta, and eotaxin) in patients with atopic dermatitis
68. A Th2 chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin
69. Impaired host defense, hematopoiesis, granulomatous inflammation and type l-type 2 cytokine balance in mice lacking CC chemokine receptor 1
70. Regulation of inter1eukin-12 production by G-protein-coupled receptors
71. Gi2a protein deficiency: A model of inflammatory bowel disease
72. Ulcerative colitis and adenocarcinoma of the colon in Gα2-deficient mice
73. Hl-type cytokines
74. Function of PI3Kγ in thymocyte development, T cell activation, and neutrophil migration
75. Central role for G-protein-coupled phosphoinositide 3-kinase γ in inflammation
76. G-protein-coupled receptors and signaling networks: Emerging paradigms
77. Albuterol-induced downregulation of Gsα accounts for pulmonary β2-adrenoceptor desensitization in vivo
78. GTPase activating proteins for heterotrimeric G proteins: Regulators of G protein signaling (RGS) and RGS-like proteins
79. GAIP RGS4 are GTPase activating proteins fro the Gi subfamily of G protein alpha subunits
80. RGS family members: GTPase activating proteins for heterotrimeric G-protein α-subunits
81. RGS-PXI, a GAP for Gαs and sorting nexin in vesicular trafficking
82. RGS4 and GAIP are GTPase activating proteins for Gqα and block activation of phospholipase Cβ by γ-thio-GTP-Gqα
83. Inhibition of G-protein-mediated MAP kinase activation by a new mammalian gene family
84. RGSI is expressed in monocytes and acts as a GTPase-activating protein for G-protein-coupled chemoattractant receptors
85. RGSI4, a GTPase-activating protein for Gi-alpha, attenuates Gi-alpha and G13-alpha-mediated signaling pathways
86. RGS3 is a GTPase-activating protein for Gi-alpha and Gq-alpha and a potent inhibitor of signaling by GTPase-deficient forms of Gq-alpha and G11-alpha
87. A human gene encoding a putative helix-loop-helix phosphoprotein whose mRNA increases rapidly in cycloheximide-treated blood mononuclear cells
88. RGS molecule expression in murine B-lymphocytes and ability to down-regulate chemotaxis to lymphoid chemokines
89. Regulators of G protein signaling exhibit distinct patterns of gene expression and target G protein specificity in human lymphocytes
90. Regulation of T cell activation, anxiety, and male aggression by RGS2
91. Classical and new roles of β-arrestins in the regulation of G-protein-coupled receptors
92. G protein coupled receptors III. New roles for receptor kinases and β-arrestins in receptor signaling and desensitization
93. Decreased expression and activity of G-protein-coupled receptor kinases in peripheral blood mononuclear cells of patients with rheumatoid arthritis